± HEALTH Objective To evaluate the accuracy, completeness, clarity, source transparency, and readability of leading AI…+ HEALTH Background Early prediction of in-hospital mortality in critically ill patients can aid clinicians in optimiz…+ HEALTH Hypertension is a major risk factor for cardiovascular diseases, with changes in gut microbiota composition a…+ SCIENCE Fire ants (Solenopsis spp. Westwood) pose a major ecological and economic threat, mainly due to the invasive…± HEALTH Objectives The current study aimed to quantify the diagnostic accuracy of commonly utilized chatbots includin…+ HEALTH Objective Despite elevated risk for epilepsy following traumatic brain injury (TBI), there are limited tools…± HEALTH Timely and accurate diagnosis of ST-elevation myocardial infarction (STEMI) is critical in military operation…+ HEALTH Colorectal cancer (CRC) exhibits substantial metabolic heterogeneity. This study developed a robust prognosti…
TruaceTracing the truth around AIWednesday, August 5, 2026
Subscribe
TRV-2026-0575Certified recordPeer-reviewed

AI-based clinician decision support system for diagnosis of inherited retinal diseases: a multicenter, randomized trial

The accurate and timely diagnosis of inherited retinal diseases (IRDs) represents an unmet clinical need in ophthalmology, as the current pathways rely on resource-intensive phenotyping, multidisciplinary expertise and genetic testing. Here we developed Retina4IRD, an artificial intelligence (AI)-based clinician decision support system (CDSS) that predicts 17 genotype categories from retina images. Retina4IRD uses a Vision Transformer model pretrained with RETFound. We then trained and validated Retina4IRD using…

Health · G Space — documented gain · certified 2026-07-27 · v1 · article view · machine-readable

Current reading — gain

Clinicians assisted by Retina4IRD achieved higher top-5 genetic diagnosis accuracy and better downstream management scores for suspected inherited retinal disease compared to specialist-only care.

Evidence

Reader signal

How should this claim be treated?

Cite this record

Truvace Impact Record TRV-2026-0575, v1: “AI-based clinician decision support system for diagnosis of inherited retinal diseases: a multicenter, randomized trial.” Truvace, 2026-07-27. /record/TRV-2026-0575 (accessed at citation time). sha256 f0a66ad73dbaaaf7…

Calibration history

Every change to this record since certification, in the open. None yet — the reading has held since it entered the record.

  1. Certifiedv1f0a66ad73dba…

    Certified into the record

Verify this record
How to verify without trusting this page

Fetch the canonical text of any version from /api/record/TRV-2026-0575 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.